1.      Abend NS, Loddenkemper T. Pediatric status epilepticus management. Current opinion in pediatrics. 2014;26(6):668-674.

2.      AKÇAY N, ŞEVKETOĞLU E. Status Epileptikus ve Yönetimi. Turkiye Klinikleri Pediatric Intensive Care-Special Topics. 2021;2(3):76-80.

3.      Arkilo D, Gustafson M, Ritter FJ. Clinical experience of intravenous lacosamide in infants and young children. Eur J Paediatr Neurol. Mar 2016;20(2):212-217. doi:10.1016/j.ejpn.2015.12.013

4.      Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocritical care. 2012;17(1):3-23.

5.      CANPOLAT M, KUMANDAŞ S. Çocuklarda Status Epileptikus Yönetimi. Turkiye Klinikleri Pediatric Sciences-Special Topics. 2018;14(1):58-81.

6.      Chamberlain JM, Okada P, Holsti M, et al. Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial. Jama. 2014;311(16):1652-1660.

7.      Chin RF, Neville BG, Peckham C, et al. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet. Jul 15 2006;368(9531):222-9. doi:10.1016/S0140-6736(06)69043-0

8.      Drislane FW. Presentation, evaluation, and treatment of nonconvulsive status epilepticus. Epilepsy Behav. Oct 2000;1(5):301-14. doi:10.1006/ebeh.2000.0100

9.      Fabene P, Marzola P, Sbarbati A, Bentivoglio M. Magnetic resonance imaging of changes elicited by status epilepticus in the rat brain: diffusion-weighted and T2-weighted images, regional blood volume maps, and direct correlation with tissue and cell damage. Neuroimage. 2003;18(2):375-389.

10.  Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy currents. 2016;16(1):48-61.

11.  Haspolat Ş GE, Sönmez M, Topaloğlu H, Tekgül H, Gürer YK, (Türkiye Çocuk Nöroloji Derneği Yönetim kurulu ve Yayın Kurulu). Ankara: Anıl Grup Matbaacılık; . Çocuk Nörolojisi. 2010:327-32.

12.  Hocker S. Systemic complications of status epilepticus—an update. Epilepsy & behavior. 2015;49:83-87.

13.  Hocker SE. Status epilepticus. CONTINUUM: Lifelong Learning in Neurology. 2015;21(5):1362-1383.

14.  Husain A, Horn G, Jacobson M. Non-convulsive status epilepticus: usefulness of clinical features in selecting patients for urgent EEG. Journal of Neurology, Neurosurgery & Psychiatry. 2003;74(2):189-191.

15.  Kravljanac R, Djuric M, Jankovic B, Pekmezovic T. Etiology, clinical course and response to the treatment of status epilepticus in children: a 16-year single-center experience based on 602 episodes of status epilepticus. european journal of paediatric neurology. 2015;19(5):584-590.

16.  Lewena S, Pennington V, Acworth J, et al. Emergency management of pediatric convulsive status epilepticus: a multicenter study of 542 patients. Pediatric emergency care. 2009;25(2):83-87.

17.  Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. New England Journal of Medicine. 1998;339(12):792-798.

18.  Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus. (1528-1167 (Electronic))

19.  Trinka E, Kälviäinen R. 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure. 2017;44:65-73.

20.  Walker MC. Pathophysiology of status epilepticus. Neuroscience letters. 2018;667:84-91.

21.  Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure. 2014;23(3):167-174.